Table 1 Overview of participant characteristics
Variable category | Low inflammation (n=6) | Medium inflammation (n=25) | High Inflammation (n=12) | p value |
|---|---|---|---|---|
Ethnicity (Caucasian) no., % | 5 (83%) | 22 (88%) | 9 (75%) | 0.598^ |
Age (median ± SD; range) | 25 ± 11.2 (19–46) | 37 ± 12.1 (21–64) | 42.5 ± 24.04 (23–88) | 0.171χ |
Vaginal pH (median ± SD; range) | 4.25 ± 0.24 (4.0–4.7) | 4.7 ± 0.44 (4.0–5.5) | 4.8 ± 0.46 (4.0–5.8) | 0.034χ |
BV+ (Amsel criteria), no., % | 0 (0%) | 4 (16%) | 4 (33%) | 0.248^ |
Vaginal symptoms in the past month, any (no., %)a | 4 (67%) | 9 (36%) | 3 (25%) | 0.222^ |
Ectopy (no., %) | 0 (0%) | 7 (28%) | 3 (25%) | 0.473^ |
Any intercourse past 30 days | 4 (67%) | 15 (60%) | 4 (42%) | 0.631^ |
Condom use (no., %) | 0 (0%) | 6 (24%) | 3 (25%) | 0.598^ |
Any birth control use | 1 (17%) Oral—1 | 10 (40%) Oral—2 Ring—2 IUD—6 | 2 (17%) Oral—1 IUD—1 | 0.328^ |
Any STI, ever (no., %) | 0 (0%) | 10 (40%) | 2 (17%) | 0.117^ |
Lactobacillus dominant microbiome | 6 (100%) | 16 (64%) | 7 (58%) | 0.184^ |